Universal Health Services (UHS) Earnings Date & Reports

Universal Health Services delivered robust Q1 2026 results for the three-month period ended March 31, 2026. Consolidated net revenues totaled $4.495 billion, surpassing consensus estimates of roughly $4.39 billion and marking a 9.6% YoY increase from $4.100 billion.

Operating income climbed to $502.9 million from $454.8 million. Net income attributable to UHS was $348.7 million, yielding GAAP diluted EPS of $5.65, well above the $4.80 reported in Q1 2025. Adjusted diluted EPS stood at $5.62, exceeding analyst forecasts in the $5.3-$5.5 range and improving from $4.84 YoY. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) net of noncontrolling interests reached $648.3 million, with a 14.4% margin.

Segment performance drove the beat. Acute Care Services revenues grew 8.2% on the same-facility basis, with operating income at $301.1 million (12.2% of revenues), up from $260.3 million. Adjusted patient days rose 0.8%, and revenue per adjusted patient day increased 5.5%. Behavioral Health Services revenues increased 7.3%, with operating income of $366.3 million (20.1% margin), compared to $338.0 million. Adjusted patient days were up 1.6%, and revenue per adjusted patient day gained 5.8%.

The company repurchased 675,000 shares for $127.3 million and reported net cash from operations of $402 million.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your research process.

Market Reaction and Investor Sentiment

Following the April 27 after-market release, UHS shares rose approximately 3.6% in after-hours trading, reflecting positive investor response to the earnings beat and revenue growth. Sentiment appears optimistic heading into the April 28 earnings conference call, with focus on segment strength amid stable volumes and pricing power. However, broader healthcare sector pressures, including labor costs, tempered some enthusiasm.

Forward Outlook and Key Factors to Monitor

Investors should track UHS's performance in upcoming quarters, building on Q1 momentum. Key areas include patient volume trends in Acute Care, where adjusted admissions were flat but revenue per case rose, and Behavioral Health, which showed modest volume gains.

Operational metrics like occupancy rates—66.8% in Acute Care and 73.2% in Behavioral Health—warrant attention, alongside cost management for supplies and labor. Days sales outstanding increased slightly to 55 days, signaling potential cash flow dynamics.

Capital expenditures of $217.2 million support facility expansions, while debt levels at $4.708 billion remain manageable. Share repurchases indicate confidence in valuation. Broader factors such as reimbursement rates from government payers and elective procedure demand will shape results. Monitor the earnings call for commentary on these trends.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.